Clinical Trials
14 trialsNCT04017962 2025-08-11
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT02396134 2025-03-03
Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
City of Hope Medical Center
Phase 2 Completed
NCT00285259 2024-10-21
Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)
Astellas Pharma Inc
Phase 2 Completed
NCT04693637 2024-05-09
Prevent
AlloVir
Phase 2/3 Completed
NCT01588015 2024-04-02
Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant
City of Hope Medical Center
Phase 1 Completed
NCT03067155 2022-12-21
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation.
University Hospital, Ghent
Phase 2 Completed
NCT01972035 2022-04-12
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
University of Minnesota
Phase 2 Completed
NCT00000712 2021-11-04
A Multicenter, Double Blind, Comparative Study of Zidovudine Alone Versus Zidovudine and Acyclovir as Treatment for HIV-Infected Patients With CD4+ Counts Less Than 200 Cells/mm3
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT01535885 2021-10-25
ACE
Medical College of Wisconsin
Phase 1 Completed
NCT02108522 2021-07-20
CHARMS
AlloVir
Phase NA Completed
NCT00400322 2021-03-01
Efficacy and Safety of Valcyte® as an add-on Therapy in Patients With Malignant Glioblastoma and Cytomegalovirus (CMV) Infection
Karolinska Institutet
Phase NA Completed
NCT00716911 2015-06-08
Measuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone Marrow Transplant or Peripheral Blood Stem Cell Transplant
City of Hope Medical Center
Phase NA Completed
NCT01070797 2014-09-04
VIRAGE
Baylor College of Medicine
Phase 1 Completed
NCT00712634 2009-12-21
Cytomegalovirus Vaccine in Healthy Participants
City of Hope Medical Center
Phase 1 Completed